Fertility preservation is a substantial quality of life issue for young cancer
survivors. As a consequence, the demand for fertility preservation has dramatically increased.
The aim of the Congress is to update current scientific and clinical development of fertility
preservation strategies. The Congress will not only propagate the current knowledge but also
provide an opportunity for networking.
This congress is designed for reproductive endocrinologists,
hematology-oncologists, gynecologic oncologists, psychologists, basic scientists, clinical
researchers, oncology nurses, REI nurses, oncology social workers and others interested in
At the completion of this congress, participants should be able to:
• Educate medical professionals to facilitate FP referrals.
• Define the ethical and legal issues related to FP.
• Explain the impact of cancer treatment on fertility and reproduction.
• Evaluate the current status of gamete cryopreservation.
• Assess the strategies and values of emerging technology in ovarian transplantation.
• Recognize the basic physiology and effects of cryopreservation.
• Analyze physiology and current techniques of folliculogenesis and IVM.
• Identify new fertility preservation technologies.